KP415
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for KP415, covering 2021-06-30 to 2021-07-19. Get the full timeline:
Most recent: Clinical Trial Update: KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD [Phase 3]